Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

TSX:EDT - Post by User

Spectral Medical Inc > "Confirmed"

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Oct 17, 2022 10:41pm

255 Views

Post# 35030533

RE:RE:"Confirmed"

Let's play connect the dots.

here's one ...

maybe the delay in the announcement of the start of the Trial, and the as yet identified Trial partner, and the lack of allocation of equity/debenture raise dollars towards the Dialco Div., and the need to involve Infomed, has something to do with a much bigger deal ( in the works) with said Trial Partner ?

Nah.... it couldn't be that.

MM